Xencor, Inc.
ICOS TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND ICOS ANTIGEN BINDING DOMAINS

Last updated:

Abstract:

The present invention is directed to novel targeted heterodimeric Fc fusion proteins comprising an IL-15/IL-15R.alpha. Fc-fusion protein and a ICOS antibody fragment-Fc fusion protein.

Status:
Application
Type:

Utility

Filling date:

23 Dec 2021

Issue date:

21 Jul 2022